Report copyright - A Phase I, First-in-Human Study Evaluating the Safety and … · 2018. 12. 3. · – reversible veno-occlusive disease (VOD) (2 DLTs) • 0.45 mg/kg moderate VOD, alloSCT for MDS
Please pass captcha verification before submit form
Please pass captcha verification before submit form